SwePub
Sök i LIBRIS databas

  Extended search

id:"swepub:oai:prod.swepub.kib.ki.se:150334303"
 

Search: id:"swepub:oai:prod.swepub.kib.ki.se:150334303" > DNA Methylation Sig...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist
LIBRIS Formathandbok  (Information om MARC21)
FältnamnIndikatorerMetadata
00003231naa a2200529 4500
001oai:prod.swepub.kib.ki.se:150334303
003SwePub
008240701s2022 | |||||||||||000 ||eng|
024a http://kipublications.ki.se/Default.aspx?queryparsed=id:1503343032 URI
024a https://doi.org/10.3390/ijms231480012 DOI
040 a (SwePub)ki
041 a engb eng
042 9 SwePub
072 7a ref2 swepub-contenttype
072 7a art2 swepub-publicationtype
100a Verberne, EA4 aut
2451 0a DNA Methylation Signature for JARID2-Neurodevelopmental Syndrome
264 c 2022-07-20
264 1b MDPI AG,c 2022
520 a JARID2 (Jumonji, AT Rich Interactive Domain 2) pathogenic variants cause a neurodevelopmental syndrome, that is characterized by developmental delay, cognitive impairment, hypotonia, autistic features, behavior abnormalities and dysmorphic facial features. JARID2 encodes a transcriptional repressor protein that regulates the activity of various histone methyltransferase complexes. However, the molecular etiology is not fully understood, and JARID2-neurodevelopmental syndrome may vary in its typical clinical phenotype. In addition, the detection of variants of uncertain significance (VUSs) often results in a delay of final diagnosis which could hamper the appropriate care. In this study we aim to detect a specific and sensitive DNA methylation signature for JARID2-neurodevelopmental syndrome. Peripheral blood DNA methylation profiles from 56 control subjects, 8 patients with (likely) pathogenic JARID2 variants and 3 patients with JARID2 VUSs were analyzed. DNA methylation analysis indicated a clear and robust separation between patients with (likely) pathogenic variants and controls. A binary model capable of classifying patients with the JARID2-neurodevelopmental syndrome was constructed on the basis of the identified episignature. Patients carrying VUSs clustered with the control group. We identified a distinct DNA methylation signature associated with JARID2-neurodevelopmental syndrome, establishing its utility as a biomarker for this syndrome and expanding the EpiSign diagnostic test.
700a van der Laan, L4 aut
700a Haghshenas, S4 aut
700a Rooney, K4 aut
700a Levy, MA4 aut
700a Alders, M4 aut
700a Maas, SM4 aut
700a Jansen, S4 aut
700a Lieden, Au Karolinska Institutet4 aut
700a Anderlid, BMu Karolinska Institutet4 aut
700a Rafael-Croes, L4 aut
700a Campeau, PM4 aut
700a Chaudhry, A4 aut
700a Koolen, DA4 aut
700a Pfundt, R4 aut
700a Hurst, ACE4 aut
700a Tran-Mau-Them, F4 aut
700a Bruel, AL4 aut
700a Lambert, L4 aut
700a Isidor, B4 aut
700a Mannens, MMAM4 aut
700a Sadikovic, B4 aut
700a Henneman, P4 aut
700a van Haelst, MM4 aut
710a Karolinska Institutet4 org
773t International journal of molecular sciencesd : MDPI AGg 23:14q 23:14x 1422-0067
8564 8u http://kipublications.ki.se/Default.aspx?queryparsed=id:150334303
8564 8u https://doi.org/10.3390/ijms23148001

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view